{
    "clinical_study": {
        "@rank": "18360", 
        "acronym": "MICROPOLY", 
        "arm_group": [
            {
                "arm_group_label": "DR4 homozygous RA", 
                "description": "This group is composed of 25 patients with RA and who are homozygous for the HLA-DR4 allele.  The diagnosis of RA is based upon the American College of Rheumatology criteria.\nIntervention: Plasma analysis for bacterial translocation\nIntervention: Stool analysis"
            }, 
            {
                "arm_group_label": "DR4 homozygous volunteer", 
                "description": "This group is composed of 25 healthy volunteers who are homozygous for the HLA-DR4 allele and who do not have RA.\nIntervention: Plasma analysis for bacterial translocation\nIntervention: Stool analysis"
            }
        ], 
        "brief_summary": {
            "textblock": "The main objective of this study is to compare the intestinal microbiota in newly diagnosed\n      patients with homozygous DR4 rheumatoid arthritis (RA)with that from DR4 homozygous\n      individuals without RA.\n\n      The first analysis will compare the proportion of filamentous bacteria in the intestinal\n      microbiota between the two groups."
        }, 
        "brief_title": "Evaluation of the Intestinal Microbiota and Bacterial Translocation in Patients With DR4 Homozygous Rheumatoid Arthritis", 
        "completion_date": {
            "#text": "March 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Arthritis, Rheumatoid", 
        "condition_browse": {
            "mesh_term": [
                "Arthritis", 
                "Arthritis, Rheumatoid"
            ]
        }, 
        "detailed_description": {
            "textblock": "The secondary objectives of this study are :\n\n        -  A. To compare between the two groups :\n\n        -  a. The proportion of Proteus mirabilis in the intestinal microbiota\n\n        -  b . The proportion of species producing peptidyl arginine deaminase (PAD ) in the\n           intestinal microbiota\n\n        -  c . The number of species found in the intestinal microbiota\n\n        -  B. To evaluate bacterial translocation (from the digestive tract) in patients with\n           newly diagnosed, homozygous DR4 RA and homozygous DR4 healthy volunteers without RA.\n           (Bacterial translocation is a phenomenon in which live bacteria or a part of bacteria\n           (e.g. LPS teicho\u00efc acid) cross the intestinal barrier and reach the bloodstream.)\n\n        -  C. To describe the ecology of the intestinal microbiota of patients with homozygous DR4\n           RA (characterization of species found according to their respiratory metabolism,\n           according to their bacteriological characteristics, and according to wether or not the\n           species are found significantly more frequently in patients with RA than in individuals\n           without RA)."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria for RA patients:\n\n          -  The patient was correctly informed\n\n          -  The patient must have given his/her informed and signed consent\n\n          -  The patient must be insured or beneficiary of a health insurance plan\n\n          -  Homozygous for the HLA-DR4 allele\n\n          -  No antibiotic treatments within the 30 days preceding inclusion\n\n          -  RA diagnosis made within the past 12 months\n\n        Exclusion Criteria for RA patients:\n\n          -  The patient has participated in another study within the past 3 months\n\n          -  The patient is under judicial protection, or any kind of guardianship\n\n          -  The patient refuses to sign the consent\n\n          -  It is impossible to correctly inform the patient\n\n          -  The patient is pregnant, parturient, or breastfeeding\n\n          -  The patient is not homozygous for the HLA-DR4 allele\n\n          -  The patient has taken antibiotics in the 30 days preceding inclusion\n\n          -  RA was diagnosed more than 12 months ago\n\n        Inclusion Criteria for healthy volunteers (HV):\n\n          -  The HV was correctly informed\n\n          -  The HV must have given his/her informed and signed consent\n\n          -  The HV must be insured or beneficiary of a health insurance plan\n\n          -  Homozygous for the HLA-DR4 allele\n\n          -  No antibiotic treatments within the 30 days preceding inclusion\n\n          -  Does not have RA\n\n        Exclusion Criteria for HVs:\n\n          -  The HV has participated in another study within the past 3 months\n\n          -  The HV is under judicial protection, or any kind of guardianship\n\n          -  The HV refuses to sign the consent\n\n          -  It is impossible to correctly inform the HV\n\n          -  The HV is pregnant, parturient, or breastfeeding\n\n          -  The HV is not homozygous for the HLA-DR4 allele\n\n          -  The HV has taken antibiotics in the 30 days preceding inclusion"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "A total of 50 adult subjects will be included: 25 with newly diagnosed RA (<12 months)\n        based on the American College of Rheumatology criteria, and 25 healthy volunteers without\n        RA.\n\n        All subjects are homozygous for the HLA-DR4 allele."
            }
        }, 
        "enrollment": {
            "#text": "50", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 9, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01961310", 
            "org_study_id": "AOIt/2012/JPL-01", 
            "secondary_id": "2013-A00888-37"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "DR4 homozygous RA", 
                    "DR4 homozygous volunteer"
                ], 
                "description": "1 ml of plasma will be obtained (blood sample).  DNA will be extracted and amplified, and real-time quantitative PCR (polymerase chain reaction) performed.", 
                "intervention_name": "Plasma analysis for bacterial translocation", 
                "intervention_type": "Biological"
            }, 
            {
                "arm_group_label": [
                    "DR4 homozygous RA", 
                    "DR4 homozygous volunteer"
                ], 
                "description": "DNA from stool samples will be extracted, amplified, and used to identify the bacteria species present.", 
                "intervention_name": "Stool analysis", 
                "intervention_type": "Biological"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "bacterial translocation", 
            "intestinal microbiota"
        ], 
        "lastchanged_date": "March 3, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Montpellier", 
                        "country": "France", 
                        "zip": "34295"
                    }, 
                    "name": "CHRU de Montpellier - H\u00f4pital Lapeyronie"
                }, 
                "investigator": [
                    {
                        "last_name": "Christian Jorgensen, MD, PhD", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Yves Marie Pers, MD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Pierre Le Blay, MD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Rosanna Ferreira, MD", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "N\u00eemes Cedex 2", 
                        "country": "France", 
                        "zip": "30908"
                    }, 
                    "name": "Unit\u00e9 U1047 \"Bacterial virulence and infectious diseases\", UFR de M\u00e9decine"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "N\u00eemes Cedex 9", 
                        "country": "France", 
                        "zip": "30029"
                    }, 
                    "name": "CHRU de N\u00eemes - H\u00f4pital Universitaire Car\u00e9meau"
                }, 
                "status": "Active, not recruiting"
            }
        ], 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_groups": "2", 
        "official_title": "Evaluation of the Intestinal Microbiota and Bacterial Translocation in Patients With DR4 Homozygous Rheumatoid Arthritis", 
        "overall_contact": {
            "email": "dunyachcatherine@yahoo.fr", 
            "last_name": "Catherine Dunyach-Remy, PharmD, PhD", 
            "phone": "+33.(0)4.66.02.81.49"
        }, 
        "overall_contact_backup": {
            "email": "carey.suehs@chu-nimes.fr", 
            "last_name": "Carey Suehs, PhD", 
            "phone": "+33.(0)4.66.68.67.88"
        }, 
        "overall_official": [
            {
                "affiliation": "Centre Hospitalier Universitaire de N\u00eemes", 
                "last_name": "Catherine Dunyach-Rempy, PharmD, PhD", 
                "role": "Study Director"
            }, 
            {
                "affiliation": "Centre Hospitalier Universitaire de N\u00eemes", 
                "last_name": "Jean Philippe Lavigne, MD, PhD", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": [
                "France: Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des produits de sant\u00e9", 
                "France: Committee for the Protection of Personnes"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "The proportion of filamentous bacteria in the intestinal microbiota", 
            "safety_issue": "No", 
            "time_frame": "Baseline (day 0)"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01961310"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "The proportion of Proteus mirabilis in the intestinal microbiota", 
                "safety_issue": "No", 
                "time_frame": "baseline (Day 0)"
            }, 
            {
                "measure": "The proportion of species producing peptidyl arginine desaminase (PAD) in the intestinal microbiota", 
                "safety_issue": "No", 
                "time_frame": "baseline (Day 0)"
            }, 
            {
                "measure": "The number of species found in the intestinal microbiota", 
                "safety_issue": "No", 
                "time_frame": "baseline (Day 0)"
            }, 
            {
                "measure": "Presence/absence of bacterial translocation", 
                "safety_issue": "No", 
                "time_frame": "baseline (Day 0)"
            }, 
            {
                "description": "Diversity indices according to species and/or functional groups.  The general goal is to provide a description of the functional differences between groups.", 
                "measure": "Description of the ecology of intestinal microbiota", 
                "safety_issue": "No", 
                "time_frame": "baseline (Day 0)"
            }
        ], 
        "source": "Centre Hospitalier Universitaire de N\u012bmes", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Centre Hospitalier Universitaire de N\u012bmes", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2014", 
        "study_design": "Observational Model: Cohort, Time Perspective: Cross-Sectional", 
        "study_type": "Observational", 
        "verification_date": "March 2014"
    }
}